Company Filing History:
2 out of 21 
1 out of 1 Years Active: 2002-2006
Title: The Innovations of Miguel Carcagno
Introduction
Miguel Carcagno is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for retroviral infections. With a total of two patents to his name, Carcagno's work has the potential to impact the medical community significantly.
Latest Patents
Carcagno's latest patents include "Carboxymethylated retroviral regulatory proteins and interferon-alpha" and "Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating AIDS." The first patent focuses on carboxymethylated proteins that are biologically inactive yet retain their immunogenicity. This innovation can be utilized in the treatment and prevention of retroviral infections, offering a new approach to vaccine development. The second patent addresses the preparation and therapeutic use of carboxymethylated viral regulation proteins, which can be incorporated into pharmaceutical and vaccine compositions.
Career Highlights
Throughout his career, Miguel Carcagno has worked with various companies, including Neovacs and Biovacs, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in retroviral treatments.
Collaborations
Carcagno has collaborated with notable individuals such as Jay F. Rappaport and Jean-Francois Zagury. These partnerships have contributed to the advancement of his research and the development of his innovative patents.
Conclusion
Miguel Carcagno's contributions to biotechnology and his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to provide new solutions for treating retroviral infections, making him a significant figure in the field.